Related Experiment Video
Updated: Jul 19, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Cost efficiency and formulary considerations for statin therapy
1The Regence Group, 1211 W Myrtle, #110, Boise, ID 83701, USA. tkillilea.id@regence.com
The American Journal of Managed Care
|October 18, 2006
Summary
Generic statins like lovastatin and simvastatin are most cost-effective for LDL-C reduction under 40%. For greater reductions, branded rosuvastatin and ezetimibe/simvastatin offer the best value.
Area of Science:
- Cardiovascular Medicine
- Pharmacoeconomics
Background:
- Low-density lipoprotein cholesterol (LDL-C) is a primary target for reducing coronary event risk.
- Managed care must find cost-effective strategies for LDL-C reduction, especially with newer, potent statins available.
Purpose of the Study:
- To analyze the cost-efficiency of various statins for achieving different levels of LDL-C reduction.
Main Methods:
- Cost-efficiency analysis comparing different statin therapies.
- Evaluation based on cost per 1% LDL-C reduction for low-to-moderate (<40%) and high (>40%) reduction targets.
Main Results:
- For LDL-C reduction <40%, generic lovastatin and simvastatin are the most cost-efficient.
- For LDL-C reduction >40%, branded rosuvastatin and ezetimibe/simvastatin demonstrate the lowest cost per 1% LDL-C reduction.
Conclusions:
- The choice of statin for optimal cost-efficiency depends on the target LDL-C reduction percentage.
- Market changes, including generic availability and new formulations, enable significant LDL-C reduction at lower costs.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...